Suppr超能文献

越南庞贝病患儿的基因型-表型相关性及CRIM状态:单中心经验

Genotype-phenotype correlation and CRIM status in Vietnamese children with Pompe disease: a single-center experience.

作者信息

Nguyen Thanh Huong Thi, Nguyen Ngoc Trang Thi, Chu Hong Phuong Thi, Tran Hong Nhung Thi, Duong Ngoc Mai, Lu Y-Thanh, Tang Hung Sang, Tran Diep Tuan, The Nguyen Phung Nguyen

机构信息

Neonatology 2 - Metabolism - Genetics Department, Children's Hospital 1, Ho Chi Minh City, Vietnam.

Medical Genetics Institute, Ho Chi Minh City, Vietnam.

出版信息

Future Sci OA. 2025 Dec;11(1):2545723. doi: 10.1080/20565623.2025.2545723. Epub 2025 Sep 15.

Abstract

BACKGROUND

Pompe disease (PD) is a rare autosomal recessive disorder caused by pathogenic variants in the gene, resulting in deficient lysosomal acid α-glucosidase activity. Clinical manifestations range from classic infantile-onset (IOPD) to late-onset (LOPD) phenotypes. Understanding genotype-phenotype correlations in PD is essential for prognosis and individualized therapy.

METHODS

This retrospective, single-center study included 26 Vietnamese pediatric patients diagnosed with PD. Clinical, biochemical, and genetic data were systematically collected. Genotype-phenotype correlation, CRIM status distribution, and survival outcomes were analyzed.

RESULTS

Of 26 patients, 23 had IOPD and 3 had LOPD. CRIM-positive status was identified in 87.0% of IOPD and 33.3% of LOPD patients. The most frequent variants were c.1843G > A and c.1933G > C. Two previously unreported variants (c.2016del, c.1723T > C) were detected. Hypertrophic cardiomyopathy and hypotonia were universal among IOPD cases. Despite ERT administration in 52.9% of patients, overall mortality in the infantile group was 60.8%. Variant pathogenicity correlated with both CRIM status and clinical outcomes.

CONCLUSION

These findings underscore the clinical importance of comprehensive genotyping and CRIM status determination in predicting disease course and guiding therapeutic decisions. Our results further emphasize the need for population-specific variant databases to inform newborn screening and precision treatment initiatives across Southeast Asia.

摘要

背景

庞贝病(PD)是一种罕见的常染色体隐性疾病,由该基因的致病变异引起,导致溶酶体酸性α-葡萄糖苷酶活性缺乏。临床表现范围从经典的婴儿型(IOPD)到晚发型(LOPD)表型。了解PD中的基因型-表型相关性对于预后和个体化治疗至关重要。

方法

这项回顾性单中心研究纳入了26名诊断为PD的越南儿科患者。系统收集了临床、生化和基因数据。分析了基因型-表型相关性、CRIM状态分布和生存结果。

结果

26名患者中,23名患有IOPD,3名患有LOPD。87.0%的IOPD患者和33.3%的LOPD患者被确定为CRIM阳性状态。最常见的变异是c.1843G>A和c.1933G>C。检测到两个以前未报告的变异(c.2016del,c.1723T>C)。肥厚型心肌病和肌张力减退在IOPD病例中普遍存在。尽管52.9%的患者接受了ERT治疗,但婴儿组的总体死亡率为60.8%。变异致病性与CRIM状态和临床结果均相关。

结论

这些发现强调了全面基因分型和CRIM状态测定在预测疾病进程和指导治疗决策方面的临床重要性。我们的结果进一步强调了需要针对特定人群的变异数据库,以指导东南亚地区的新生儿筛查和精准治疗计划。

相似文献

3
Enzyme replacement therapy for infantile-onset Pompe disease.婴儿型庞贝病的酶替代疗法。
Cochrane Database Syst Rev. 2017 Nov 20;11(11):CD011539. doi: 10.1002/14651858.CD011539.pub2.
7
Enzyme replacement therapy for late-onset Pompe disease.用于迟发性庞贝病的酶替代疗法。
Cochrane Database Syst Rev. 2023 Dec 12;12(12):CD012993. doi: 10.1002/14651858.CD012993.pub2.

本文引用的文献

7
A Comprehensive Update on Late-Onset Pompe Disease.晚期庞贝病的全面更新。
Biomolecules. 2023 Aug 22;13(9):1279. doi: 10.3390/biom13091279.
10
Newborn Screening for Pompe Disease.庞贝病新生儿筛查
Int J Neonatal Screen. 2020 Apr 5;6(2):31. doi: 10.3390/ijns6020031. eCollection 2020 Jun.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验